Skip to Content
Faculty and Staff Resources
SHARE TEXT

Kelli Pointer

Kelli Pointer

Undergraduate
Education

Massachusetts Institute of Technology

BS (2010)
Years in MSTP 2010-
PhD Program

Cellular and Molecular Biology

Mentor

John Kuo, MD

Thesis Title

Predictive biomarkers in the investigation into glioblastoma heterogeneity: Collagen and hERG

Undergraduate and/or Masters Publications

Libert S, Bonkowski MS, Pointer K, Pletcher SD, Guarente L. Deviation of innate circadian period from 24h reduces longevity in mice. Aging Cell. 2012 Jun 15. PMID: 22702406.

 

Libert S, Pointer K, Bell EL, Das A, Cohen DE, Asara JM, Kapur K, Bergmann S, Preisig M, Otowa T, Kendler KS, Chen X, Hettema JM, van den Oord EJ, Rubio JP, Guarente L. SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell. 2011 Dec 23;147(7):1459-72. PMID: 22169038.

PhD Publications

Zhang RR, Pointer KB, Kuo JS. Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target. Neurosurgery. 2015 Dec;77(6):N16-7. PMID: 26584321.

 

Pointer K, Kuo JS, Dempsey RJ. CLARITY-A Clearer View of the Brain. Neurosurgery. 2013 Aug;73(2):N16. PMID: 23867270.

 

Pointer KB, Clark PA, Zorniak M, Alrfaei BM, Kuo JS. Glioblastoma Cancer Stem Cells: Biomarker and Therapeutic Advances. Neurochem Int. 2014 May;71C:1-7. PMID: 24657832; PMCID: PMC4119816.

 

Pointer KB, Zhang RR, Kuo JS, Dempsey RJ. Detecting brain tumor with Raman scattering microscopy. Neurosurgery. 2014 Feb;74(2):N12-4. PMID: 24435144.

 

Zhu W, Begum G, Pointer K, Clark PA, Yang SS, Lin SH, Kahle KT, Kuo JS, Sun D. WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration. Mol Cancer. 2014 Feb 20;13:31. PMID: 24555568; PMCID: PMC3936893.

 

Cong D, Zhu W, Shi Y, Pointer KB, Clark PA, Shen H, Kuo JS, Hu S, Sun D. Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H+ extrusion, cell migration and survival. Carcinogenesis. 2014 Sep;35(9):2014-24. PMID: 24717311; PMCID: PMC4146414.

 

Lyon W, Mehta TI, Pointer KB, Walden D, Elmayan A, Swanson KI, Kuo JS. Clinton Woolsey: functional brain mapping pioneer. J Neurosurg. 2014 Oct;121(4):983-8. PMID: 25105696; PMCID: PMC4354805.

 

Zhang RR, Pointer KB, Kuo JS, Dempsey RJ. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Neurosurgery. 2014 Dec;75(6):N9-N10. PMID: 25406627; PMCID: PMC4354805.

 

Pointer KB, Zhang RR, Kuo JS. Oncolytic Herpes Simplex Virus Glioblastoma Therapy is Potentiated by Tumor Necrosis Factor-α Inhibition. Neurosurgery. 2015 Aug;77(2):N18-20. PMID: 26181790.

 

Zhang RR, Pointer KB, Kuo JS. New Molecular Insights and Potential Therapies for Diffuse Intrinsic Pontine Glioma. Neurosurgery. 2015 Oct;77(4):N13-4. PMID: 26379176.

Pointer KB, Clark PA, Schroeder AB, Salamat MS, Eliceiri KW, Kuo JS. Association of collagen architecture with glioblastoma patient survival. J Neurosurg. 2016 Sep 2:1-10. [Epub ahead of print] PMID: 27588592.

 

Pointer KB, Clark PA, Eliceiri KW, Salamat MS, Robertson GA, Kuo JS. Non-torsadogenic human Ether-à-go-go Related Gene (hERG) inhibitors are associated with better survival for high hERG-expressing glioblastoma patients. Clin Cancer Res. 2016 Sep 15. pii: clincanres.3169.2016. [Epub ahead of print] PMID: 27635088. 


Kelli Pointer

Last updated: 10/18/2016
Website Feedback
Copyright © 2017 University of Wisconsin School of Medicine and Public Health
Use of this site signifies your agreement to the terms and conditions
smphweb@uwhealth.org